⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

Official Title: Evaluation of CHOP Plus Rituximab Plus Involved Field Radiotherapy for Stages I, IE, and Non-Bulky Stages II and IIE, CD20 Positive, High-Risk Localized Aggressive Histologies of Non-Hodgkin's Lymphoma

Study ID: NCT00005089

Conditions

Lymphoma

Study Description

Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Monoclonal antibodies, such as rituximab, can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. Radiation therapy uses high-energy x-rays to damage cancer cells. Combining chemotherapy with monoclonal antibody therapy and radiation therapy may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus rituximab and radiation therapy in treating patients who have stage I or stage II non-Hodgkin's lymphoma.

Detailed Description: OBJECTIVES: I. Assess two year progression free survival after treatment with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) plus rituximab followed by radiotherapy in patients with stage I, IE, or non-bulky stage II or IIE high risk localized intermediate or high grade non-Hodgkin's lymphoma. II. Determine the toxicity of this treatment in these patients. OUTLINE: Patients receive rituximab IV on days 1 and 8 of the first course, then on day 1 of courses 2 and 3. Patients receive cyclophosphamide IV over 1-2 hours, doxorubicin IV, and vincristine IV on day 10 of the first course, then on day 3 of courses 2 and 3. Patients receive oral prednisone on days 10-14 of the first course, then on days 3-7 of courses 2 and 3. Treatment repeats every 21 days for 3 courses in the absence of disease progression or unacceptable toxicity. Chemotherapy is followed by radiotherapy administered 5 days a week for 4-5 weeks. Patients are followed every 6 months for two years, and then annually thereafter. PROJECTED ACCRUAL: A total of 60 patients will be accrued for this study.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

MBCCOP - Gulf Coast, Mobile, Alabama, United States

CCOP - Greater Phoenix, Phoenix, Arizona, United States

Veterans Affairs Medical Center - Phoenix (Hayden), Phoenix, Arizona, United States

Veterans Affairs Medical Center - Tucson, Tucson, Arizona, United States

Arizona Cancer Center, Tucson, Arizona, United States

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Veterans Affairs Medical Center - Little Rock (McClellan), Little Rock, Arkansas, United States

Cancer Center and Beckman Research Institute, City of Hope, Duarte, California, United States

Veterans Affairs Medical Center - Long Beach, Long Beach, California, United States

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States

Veterans Affairs Medical Center - West Los Angeles, Los Angeles, California, United States

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States

CCOP - Bay Area Tumor Institute, Oakland, California, United States

Chao Family Comprehensive Cancer Center, Orange, California, United States

University of California Davis Medical Center, Sacramento, California, United States

CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, United States

David Grant Medical Center, Travis Air Force Base, California, United States

University of Colorado Cancer Center, Denver, Colorado, United States

Veterans Affairs Medical Center - Denver, Denver, Colorado, United States

CCOP - Atlanta Regional, Atlanta, Georgia, United States

Dwight David Eisenhower Army Medical Center, Fort Gordon, Georgia, United States

Cancer Research Center of Hawaii, Honolulu, Hawaii, United States

MBCCOP - University of Illinois at Chicago, Chicago, Illinois, United States

CCOP - Central Illinois, Decatur, Illinois, United States

Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital), Hines, Illinois, United States

Loyola University Medical Center, Maywood, Illinois, United States

University of Kansas Medical Center, Kansas City, Kansas, United States

CCOP - Wichita, Wichita, Kansas, United States

Veterans Affairs Medical Center - Wichita, Wichita, Kansas, United States

Veterans Affairs Medical Center - Lexington, Lexington, Kentucky, United States

Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, United States

MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, United States

Tulane University School of Medicine, New Orleans, Louisiana, United States

Veterans Affairs Medical Center - New Orleans, New Orleans, Louisiana, United States

Louisiana State University Health Sciences Center - Shreveport, Shreveport, Louisiana, United States

Veterans Affairs Medical Center - Shreveport, Shreveport, Louisiana, United States

Boston Medical Center, Boston, Massachusetts, United States

Veterans Affairs Medical Center - Boston (Jamaica Plain), Jamaica Plain, Massachusetts, United States

Veterans Affairs Medical Center - Ann Arbor, Ann Arbor, Michigan, United States

CCOP - Ann Arbor Regional, Ann Arbor, Michigan, United States

University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

Veterans Affairs Medical Center - Detroit, Detroit, Michigan, United States

Henry Ford Hospital, Detroit, Michigan, United States

CCOP - Grand Rapids Clinical Oncology Program, Grand Rapids, Michigan, United States

Providence Hospital - Southfield, Southfield, Michigan, United States

CCOP - Duluth, Duluth, Minnesota, United States

Veterans Affairs Medical Center - Biloxi, Biloxi, Mississippi, United States

University of Mississippi Medical Center, Jackson, Mississippi, United States

Veterans Affairs Medical Center - Jackson, Jackson, Mississippi, United States

Keesler Medical Center - Keesler AFB, Keesler AFB, Mississippi, United States

Veterans Affairs Medical Center - Kansas City, Kansas City, Missouri, United States

CCOP - Kansas City, Kansas City, Missouri, United States

St. Louis University Health Sciences Center, Saint Louis, Missouri, United States

CCOP - St. Louis-Cape Girardeau, Saint Louis, Missouri, United States

CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States

CCOP - Montana Cancer Consortium, Billings, Montana, United States

Veterans Affairs Medical Center - Albuquerque, Albuquerque, New Mexico, United States

MBCCOP - University of New Mexico HSC, Albuquerque, New Mexico, United States

Herbert Irving Comprehensive Cancer Center, New York, New York, United States

CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina, United States

Barrett Cancer Center, The University Hospital, Cincinnati, Ohio, United States

Veterans Affairs Medical Center - Cincinnati, Cincinnati, Ohio, United States

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

CCOP - Columbus, Columbus, Ohio, United States

Veterans Affairs Medical Center - Dayton, Dayton, Ohio, United States

CCOP - Dayton, Kettering, Ohio, United States

CCOP - Toledo Community Hospital Oncology Program, Toledo, Ohio, United States

Veterans Affairs Medical Center - Oklahoma City, Oklahoma City, Oklahoma, United States

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

Oregon Cancer Center, Portland, Oregon, United States

Veterans Affairs Medical Center - Portland, Portland, Oregon, United States

CCOP - Columbia River Program, Portland, Oregon, United States

CCOP - Greenville, Greenville, South Carolina, United States

CCOP - Upstate Carolina, Spartanburg, South Carolina, United States

Veterans Affairs Medical Center - Dallas, Dallas, Texas, United States

Simmons Cancer Center - Dallas, Dallas, Texas, United States

Brooke Army Medical Center, Fort Sam Houston, Texas, United States

University of Texas Medical Branch, Galveston, Texas, United States

Texas Tech University Health Science Center, Lubbock, Texas, United States

University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Veterans Affairs Medical Center - San Antonio (Murphy), San Antonio, Texas, United States

Veterans Affairs Medical Center - Temple, Temple, Texas, United States

CCOP - Scott and White Hospital, Temple, Texas, United States

Huntsman Cancer Institute, Salt Lake City, Utah, United States

Veterans Affairs Medical Center - Salt Lake City, Salt Lake City, Utah, United States

CCOP - Virginia Mason Research Center, Seattle, Washington, United States

Swedish Cancer Institute, Seattle, Washington, United States

Veterans Affairs Medical Center - Seattle, Seattle, Washington, United States

CCOP - Northwest, Tacoma, Washington, United States

Madigan Army Medical Center, Tacoma, Washington, United States

Contact Details

Name: Thomas P. Miller, MD

Affiliation: University of Arizona

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: